| Field | Row 1 |
|---|---|
| adsh | 0000950170-25-069831 |
| cik | 1991792 |
| name | CG ONCOLOGY, INC. |
| sic | 2836 |
| countryba | US |
| stprba | CA |
| cityba | IRVINE |
| zipba | 92618 |
| bas1 | 400 SPECTRUM CENTER DRIVE |
| bas2 | SUITE 2040 |
| baph | (949) 419-6203 |
| countryma | US |
| stprma | CA |
| cityma | IRVINE |
| zipma | 92618 |
| mas1 | 400 SPECTRUM CENTER DRIVE |
| mas2 | SUITE 2040 |
| countryinc | US |
| stprinc | DE |
| ein | 371611499 |
| former | |
| changed | |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250513 |
| accepted | 2025-05-13 08:30:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | ck0001991792-20250331_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0000950170-25-069831 | 20250331 | Accrued Liabilities And Other Liabilities | 15656000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Accrued Liabilities And Other Liabilities | 1978000.0000 | USD | 0 | us-gaap/2024 | Balance Sheet Location= Professional Fees; | ||
| 0000950170-25-069831 | 20241231 | Assets Current | 754210000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 8266000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20240331 | Increase Decrease In Accounts Payable | 1417000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20240331 | Net Cash Provided By Used In Investing Activities | -307444000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20240331 | Net Income Loss | -16934000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20240331 | Net Income Loss | -16934000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0000950170-25-069831 | 20250331 | Net Income Loss | -34452000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0000950170-25-069831 | 20250331 | Non Cash Lease Expense | -14000.0000 | USD | 1 | 0000950170-25-069831 | |||
| 0000950170-25-069831 | 20241231 | Operating Lease Right Of Use Asset | 221000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20240331 | Payments To Acquire Property Plant And Equipment | 12000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Payments To Acquire Short Term Investments | 361892000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Proceeds From Stock Options Exercised | 682000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Property Plant And Equipment Net | 264000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20240331 | Reclassification Of Redeemable Convertible Preferred Stock To Common Stock | 307890000.0000 | USD | 1 | 0000950170-25-069831 | |||
| 0000950170-25-069831 | 20240331 | Revenue From Contract With Customer Including Assessed Tax | 529000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0000950170-25-069831 | 20250331 | Revenue From Contract With Customer Including Assessed Tax | 100000.0000 | USD | 1 | us-gaap/2024 | Counterparty Name= Kissei Pharmaceutical Co Ltd; Range= Maximum; | ||
| 0000950170-25-069831 | 20241231 | Shares Outstanding | 76154783.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-069831 | 20241231 | Stockholders Equity | 951350000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-069831 | 20240331 | Stock Issued During Period Shares Conversion Of Convertible Securities | 38413909.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-069831 | 20240331 | Stock Issued During Period Value Conversion Of Convertible Securities | 307890000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20231231 | Temporary Equity Shares Outstanding | 53271754.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series D Redeemable Convertible Preferred Stock; Equity Components= Preferred Stock; | ||
| 0000950170-25-069831 | 20240331 | Temporory Equity Issued During Period Shares Conversion Of Convertible Securities | -112422700.0000 | shares | 1 | 0000950170-25-069831 | Class Of Stock= Series E Redeemable Convertible Preferred Stock; Equity Components= Preferred Stock; | ||
| 0000950170-25-069831 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 47064768.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Common Stock Shares Issued | 76221289.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Depreciation Depletion And Amortization | 24000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | General And Administrative Expense | 14789000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Increase Decrease In Accrued Liabilities And Other Operating Liabilities | 836000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Increase Decrease In Other Operating Assets | 35000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20241231 | Marketable Securities Current | 484930000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20240331 | Net Income Loss | -16934000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-069831 | 20250331 | Operating Income Loss | -42204000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Operating Income Loss | -42204000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0000950170-25-069831 | 20250331 | Operating Lease Liability Noncurrent | 781000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Other Noncash Income | 176000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20240331 | Revenue From Contract With Customer Including Assessed Tax | 500000.0000 | USD | 1 | us-gaap/2024 | Counterparty Name= Lepu Biotech Co Ltd; | ||
| 0000950170-25-069831 | 20250331 | Shares Outstanding | 76221289.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-069831 | 20231231 | Stockholders Equity | -129942000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-069831 | 20240331 | Stockholders Equity | 7000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-069831 | 20240331 | Stock Issued During Period Value Conversion Of Convertible Securities | 4000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-069831 | 20231231 | Temporary Equity Shares Outstanding | 112422700.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series E Redeemable Convertible Preferred Stock; Equity Components= Preferred Stock; | ||
| 0000950170-25-069831 | 20240331 | Temporory Equity Issued During Period Shares Conversion Of Convertible Securities | -11973000.0000 | shares | 1 | 0000950170-25-069831 | Class Of Stock= Series B Redeemable Convertible Preferred Stock; Equity Components= Preferred Stock; | ||
| 0000950170-25-069831 | 20240331 | Temporory Equity Issued During Period Value Conversion Of Convertible Securities | -3570000.0000 | USD | 1 | 0000950170-25-069831 | Class Of Stock= Series A1 Redeemable Convertible Preferred Stock; Equity Components= Preferred Stock; | ||
| 0000950170-25-069831 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 47064768.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20241231 | Additional Paid In Capital | 951350000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 5151000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 5151000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-069831 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 257068000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 69202000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0000950170-25-069831 | 20240331 | General And Administrative Expense | 5788000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0000950170-25-069831 | 20240331 | Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -4127000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20240331 | Increase Decrease In Other Operating Assets | 33000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Marketable Securities Current | 646962000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Nonoperating Income Expense | 7752000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Operating Lease Right Of Use Asset | 1033000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20241231 | Other Assets Noncurrent | 94000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Other Assets Noncurrent | 516000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20241231 | Property Plant And Equipment Net | 272000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20240331 | Research And Development Expense | 17210000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0000950170-25-069831 | 20250331 | Right Of Use Asset Obtained In Exchange For Operating Lease Liability | 859000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20240331 | Stockholders Equity | 715807000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-069831 | 20240331 | Stock Issued During Period Value Conversion Of Convertible Securities | 307886000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-069831 | 20231231 | Temporary Equity Carrying Amount Attributable To Parent | 22000000.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Series C Redeemable Convertible Preferred Stock; Equity Components= Preferred Stock; | ||
| 0000950170-25-069831 | 20240331 | Temporory Equity Issued During Period Shares Conversion Of Convertible Securities | -81587937.0000 | shares | 1 | 0000950170-25-069831 | Class Of Stock= Series F Redeemable Convertible Preferred Stock; Equity Components= Preferred Stock; | ||
| 0000950170-25-069831 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 76187621.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Net Income Loss | -34452000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20240331 | Temporory Equity Issued During Period Shares Conversion Of Convertible Securities | -5075000.0000 | shares | 1 | 0000950170-25-069831 | Class Of Stock= Series A1 Redeemable Convertible Preferred Stock; Equity Components= Preferred Stock; | ||
| 0000950170-25-069831 | 20240331 | Non Cash Lease Expense | -3000.0000 | USD | 1 | 0000950170-25-069831 | |||
| 0000950170-25-069831 | 20250331 | Operating Expenses | 42256000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0000950170-25-069831 | 20241231 | Accounts Payable Current | 6517000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20241231 | Common Stock Value | 8000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20240331 | Deferred Offering Cost | -3387000.0000 | USD | 1 | 0000950170-25-069831 | |||
| 0000950170-25-069831 | 20250331 | Liabilities Current | 22642000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Net Cash Provided By Used In Operating Activities | -29277000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20241231 | Operating Lease Liability Current | 186000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Payments To Acquire Property Plant And Equipment | 16000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20240331 | Proceeds From Issuance Initial Public Offering | 406410000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20240331 | Profit Loss | -16934000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Profit Loss | -34452000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20241231 | Retained Earnings Accumulated Deficit | -217981000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Retained Earnings Accumulated Deficit | -252433000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20240331 | Revenue From Contract With Customer Including Assessed Tax | 529000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Revenue From Contract With Customer Including Assessed Tax | 52000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0000950170-25-069831 | 20250331 | Revenue From Contract With Customer Including Assessed Tax | 0.0000 | USD | 1 | us-gaap/2024 | Counterparty Name= Lepu Biotech Co Ltd; | ||
| 0000950170-25-069831 | 20240331 | Shares Outstanding | 66636252.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-069831 | 20250331 | Stockholders Equity | 704758000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20231231 | Temporary Equity Carrying Amount Attributable To Parent | 10000000.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Series B Redeemable Convertible Preferred Stock; Equity Components= Preferred Stock; | ||
| 0000950170-25-069831 | 20231231 | Temporary Equity Carrying Amount Attributable To Parent | 120000000.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Series E Redeemable Convertible Preferred Stock; Equity Components= Preferred Stock; | ||
| 0000950170-25-069831 | 20231231 | Temporary Equity Shares Outstanding | 5075000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series A1 Redeemable Convertible Preferred Stock; Equity Components= Preferred Stock; | ||
| 0000950170-25-069831 | 20250331 | Accounts Payable Current | 6731000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20241231 | Accrued Liabilities And Other Liabilities | 14665000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20241231 | Accrued Liabilities And Other Liabilities | 7181000.0000 | USD | 0 | us-gaap/2024 | Balance Sheet Location= External Research And Development Expenses; | ||
| 0000950170-25-069831 | 20250331 | Accrued Liabilities And Other Liabilities | 266000.0000 | USD | 0 | us-gaap/2024 | Balance Sheet Location= Other; | ||
| 0000950170-25-069831 | 20250331 | Accrued Liabilities And Other Liabilities | 2336000.0000 | USD | 0 | us-gaap/2024 | Balance Sheet Location= Personnel Related Expenses; | ||
| 0000950170-25-069831 | 20250331 | Additional Paid In Capital | 957183000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 77468000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 41472000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0000950170-25-069831 | 20240331 | Earnings Per Share Basic | -0.3600 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20240331 | Investment Income Interest | 5544000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20241231 | Liabilities Current | 21368000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Net Cash Provided By Used In Investing Activities | -186769000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20241231 | Notes And Loans Receivable Net Noncurrent | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Operating Expenses | 42256000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20240331 | Operating Income Loss | -22469000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0000950170-25-069831 | 20250331 | Other Nonoperating Income Expense | 5000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20240331 | Payments To Acquire Short Term Investments | 453297000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Prepaid Expense And Other Assets Current | 12413000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20240331 | Revenue From Contract With Customer Including Assessed Tax | 0.0000 | USD | 1 | us-gaap/2024 | Counterparty Name= Kissei Pharmaceutical Co Ltd; | ||
| 0000950170-25-069831 | 20240331 | Share Based Compensation | 1517000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20241231 | Stockholders Equity | 733377000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Stockholders Equity | 8000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-069831 | 20250331 | Stock Issued During Period Shares Conversion Of Convertible Securities | 38413909.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20241231 | Stock Issued During Period Shares New Issues | 8500000.0000 | shares | 0 | us-gaap/2024 | Subsidiary Sale Of Stock= Follow On Offering; | ||
| 0000950170-25-069831 | 20250331 | Stock Issued During Period Shares New Issues | 66506.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-069831 | 20240331 | Stock Issued During Period Value New Issues | 399562000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; Subsidiary Sale Of Stock= I P O; | ||
| 0000950170-25-069831 | 20240331 | Stock Issued During Period Value New Issues | 3000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; Subsidiary Sale Of Stock= I P O; | ||
| 0000950170-25-069831 | 20250331 | Stock Issued During Period Value New Issues | 682000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20231231 | Temporary Equity Shares Outstanding | 11973000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series B Redeemable Convertible Preferred Stock; Equity Components= Preferred Stock; | ||
| 0000950170-25-069831 | 20240331 | Temporory Equity Issued During Period Value Conversion Of Convertible Securities | -47300000.0000 | USD | 1 | 0000950170-25-069831 | Class Of Stock= Series D Redeemable Convertible Preferred Stock; Equity Components= Preferred Stock; | ||
| 0000950170-25-069831 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20241231 | Common Stock Shares Authorized | 700000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20241231 | Common Stock Shares Issued | 76154783.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Earnings Per Share Basic | -0.4500 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20241231 | Accrued Liabilities And Other Liabilities | 1255000.0000 | USD | 0 | us-gaap/2024 | Balance Sheet Location= Professional Fees; | ||
| 0000950170-25-069831 | 20241231 | Assets | 754797000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Assets | 728181000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20241231 | Accrued Liabilities And Other Liabilities | 436000.0000 | USD | 0 | us-gaap/2024 | Balance Sheet Location= Other; | ||
| 0000950170-25-069831 | 20241231 | Cash And Cash Equivalents At Carrying Value | 257068000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | General And Administrative Expense | 14789000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0000950170-25-069831 | 20250331 | Increase Decrease In Accounts And Other Receivables | -436000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 982000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Investment Income Interest | 7747000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20240331 | Investment Income Net Amortization Of Discount And Premium | 2199000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20240331 | Nonoperating Income Expense | 5535000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Notes And Loans Receivable Net Noncurrent | 25176000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20240331 | Operating Income Loss | -22469000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Operating Lease Liability Current | 255000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20241231 | Operating Lease Liability Noncurrent | 52000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20240331 | Other Nonoperating Income Expense | 5535000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0000950170-25-069831 | 20240331 | Payments Of Success Fee Or Long Term Debt | 365000.0000 | USD | 1 | 0000950170-25-069831 | |||
| 0000950170-25-069831 | 20250331 | Payments To Acquire Notes Receivable | 25000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20241231 | Prepaid Expense And Other Assets Current | 11431000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Proceeds From Sale Maturity And Collection Of Shortterm Investments | 200139000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Revenue From Contract With Customer Including Assessed Tax | 52000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Share Based Compensation | 5151000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20231231 | Stockholders Equity | -123100000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20240331 | Stockholders Equity | 568938000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20240331 | Stockholders Equity | -146876000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-069831 | 20250331 | Stockholders Equity | 957183000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-069831 | 20240331 | Stock Issued During Period Shares New Issues | 60.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-069831 | 20250331 | Stock Issued During Period Value New Issues | 682000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-069831 | 20231231 | Temporary Equity Carrying Amount Attributable To Parent | 47300000.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Series D Redeemable Convertible Preferred Stock; Equity Components= Preferred Stock; | ||
| 0000950170-25-069831 | 20231231 | Temporary Equity Carrying Amount Attributable To Parent | 105020000.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Series F Redeemable Convertible Preferred Stock; Equity Components= Preferred Stock; | ||
| 0000950170-25-069831 | 20231231 | Temporary Equity Shares Outstanding | 81587937.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series F Redeemable Convertible Preferred Stock; Equity Components= Preferred Stock; | ||
| 0000950170-25-069831 | 20240331 | Temporory Equity Issued During Period Value Conversion Of Convertible Securities | -22000000.0000 | USD | 1 | 0000950170-25-069831 | Class Of Stock= Series C Redeemable Convertible Preferred Stock; Equity Components= Preferred Stock; | ||
| 0000950170-25-069831 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 76187621.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Accounts And Other Receivables Net Current | 345000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20241231 | Accrued Liabilities And Other Liabilities | 5793000.0000 | USD | 0 | us-gaap/2024 | Balance Sheet Location= Personnel Related Expenses; | ||
| 0000950170-25-069831 | 20241231 | Common Stock Shares Outstanding | 76154783.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Common Stock Shares Outstanding | 76221289.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Deferred Offering Cost | -232000.0000 | USD | 1 | 0000950170-25-069831 | |||
| 0000950170-25-069831 | 20250331 | Deferred Offering Costs Unpaid And Accrued | 215000.0000 | USD | 0 | 0000950170-25-069831 | |||
| 0000950170-25-069831 | 20240331 | Earnings Per Share Diluted | -0.3600 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20240331 | General And Administrative Expense | 5788000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Investment Income Net Amortization Of Discount And Premium | 279000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20241231 | Liabilities | 21420000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20241231 | Liabilities And Stockholders Equity | 754797000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Liabilities And Stockholders Equity | 728181000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20240331 | Net Cash Provided By Used In Financing Activities | 402658000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20240331 | Net Cash Provided By Used In Operating Activities | -26012000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Notes And Loans Receivable Net Noncurrent | 25000000.0000 | USD | 0 | us-gaap/2024 | Consolidated Entities= Subsidiaries; Debt Instrument= Convertible Promissory Note; | ||
| 0000950170-25-069831 | 20240331 | Proceeds From Sale Maturity And Collection Of Shortterm Investments | 145865000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Research And Development Expense | 27467000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0000950170-25-069831 | 20241231 | Stockholders Equity | -217981000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-069831 | 20250331 | Stockholders Equity | -252433000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-069831 | 20231231 | Temporary Equity Shares Outstanding | 73598283.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series C Redeemable Convertible Preferred Stock; Equity Components= Preferred Stock; | ||
| 0000950170-25-069831 | 20240331 | Temporory Equity Issued During Period Shares Conversion Of Convertible Securities | -73598283.0000 | shares | 1 | 0000950170-25-069831 | Class Of Stock= Series C Redeemable Convertible Preferred Stock; Equity Components= Preferred Stock; | ||
| 0000950170-25-069831 | 20240331 | Temporory Equity Issued During Period Value Conversion Of Convertible Securities | -10000000.0000 | USD | 1 | 0000950170-25-069831 | Class Of Stock= Series B Redeemable Convertible Preferred Stock; Equity Components= Preferred Stock; | ||
| 0000950170-25-069831 | 20240331 | Temporory Equity Issued During Period Value Conversion Of Convertible Securities | -120000000.0000 | USD | 1 | 0000950170-25-069831 | Class Of Stock= Series E Redeemable Convertible Preferred Stock; Equity Components= Preferred Stock; | ||
| 0000950170-25-069831 | 20241231 | Accounts And Other Receivables Net Current | 781000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Accrued Liabilities And Other Liabilities | 215000.0000 | USD | 0 | us-gaap/2024 | Balance Sheet Location= Deferred Offering Costs; | ||
| 0000950170-25-069831 | 20250331 | Accrued Liabilities And Other Liabilities | 10861000.0000 | USD | 0 | us-gaap/2024 | Balance Sheet Location= External Research And Development Expenses; | ||
| 0000950170-25-069831 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 1517000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 1517000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-069831 | 20250331 | Assets Current | 701192000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Cash And Cash Equivalents At Carrying Value | 41472000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -215596000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Common Stock Shares Authorized | 700000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Common Stock Value | 8000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20240331 | Conversion Of Deferred Offering Costs | 6845000.0000 | USD | 1 | 0000950170-25-069831 | |||
| 0000950170-25-069831 | 20240331 | Depreciation Depletion And Amortization | 4000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Earnings Per Share Diluted | -0.4500 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Increase Decrease In Accounts Payable | 214000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 5654000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Liabilities | 23423000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Net Cash Provided By Used In Financing Activities | 450000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Net Income Loss | -34452000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-069831 | 20240331 | Operating Expenses | 22998000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20240331 | Operating Expenses | 22998000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0000950170-25-069831 | 20240331 | Other Nonoperating Income Expense | -9000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Other Nonoperating Income Expense | 7752000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0000950170-25-069831 | 20240331 | Research And Development Expense | 17210000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20250331 | Research And Development Expense | 27467000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20231231 | Shares Outstanding | 5222283.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-069831 | 20231231 | Stockholders Equity | 6842000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-069831 | 20241231 | Stockholders Equity | 8000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-069831 | 20240131 | Stock Issued During Period Shares New Issues | 23000000.0000 | shares | 0 | us-gaap/2024 | Subsidiary Sale Of Stock= I P O; | ||
| 0000950170-25-069831 | 20240331 | Stock Issued During Period Shares New Issues | 23000000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; Subsidiary Sale Of Stock= I P O; | ||
| 0000950170-25-069831 | 20240331 | Stock Issued During Period Value New Issues | 399565000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-069831 | 20231231 | Temporary Equity Carrying Amount Attributable To Parent | 3570000.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Series A1 Redeemable Convertible Preferred Stock; Equity Components= Preferred Stock; | ||
| 0000950170-25-069831 | 20240331 | Temporory Equity Issued During Period Shares Conversion Of Convertible Securities | -53271754.0000 | shares | 1 | 0000950170-25-069831 | Class Of Stock= Series D Redeemable Convertible Preferred Stock; Equity Components= Preferred Stock; | ||
| 0000950170-25-069831 | 20250331 | Temporory Equity Issued During Period Shares Conversion Of Convertible Securities | 38413909.0000 | shares | 1 | 0000950170-25-069831 | |||
| 0000950170-25-069831 | 20240331 | Temporory Equity Issued During Period Value Conversion Of Convertible Securities | -105020000.0000 | USD | 1 | 0000950170-25-069831 | Class Of Stock= Series F Redeemable Convertible Preferred Stock; Equity Components= Preferred Stock; |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Operating Lease Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
| Payments To Acquire Property Plant And Equipment | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | us-gaap/2024 | 0 | 0 | monetary | D | D | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | Amount of increase in right-of-use asset obtained in exchange for operating lease liability. |
| Reclassification Of Redeemable Convertible Preferred Stock To Common Stock | 0000950170-25-069831 | 1 | 0 | monetary | D | D | Reclassification Of Redeemable Convertible Preferred Stock To Common Stock | Reclassification of redeemable convertible preferred stock to common stock. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Proceeds From Stock Options Exercised | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Stock Options Exercised | Amount of cash inflow from exercise of option under share-based payment arrangement. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Temporory Equity Issued During Period Value Conversion Of Convertible Securities | 0000950170-25-069831 | 1 | 0 | monetary | D | C | Temporory equity issued during period value conversion of convertible securities | Temporory equity issued during period value conversion of convertible securities. |
| Additional Paid In Capital | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Other Noncash Income | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Noncash Income | Amount of income or gain included in net income that result in no cash inflow (outflow), classified as other. |
| Temporary Equity Carrying Amount Attributable To Parent | us-gaap/2024 | 0 | 0 | monetary | I | C | Temporary Equity, Carrying Amount, Attributable to Parent | Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer. |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Stock Issued During Period Value Conversion Of Convertible Securities | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Conversion of Convertible Securities | The gross value of stock issued during the period upon the conversion of convertible securities. |
| Temporory Equity Issued During Period Shares Conversion Of Convertible Securities | 0000950170-25-069831 | 1 | 0 | shares | D | Temporory equity issued during period shares conversion of convertible securities | Temporory equity issued during period shares conversion of convertible securities. | |
| Non Cash Lease Expense | 0000950170-25-069831 | 1 | 0 | monetary | D | D | Non Cash Lease Expense | Non cash lease expense. |
| Accrued Liabilities And Other Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Accrued Liabilities and Other Liabilities | Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other. |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Increase Decrease In Accounts And Other Receivables | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Accounts and Other Receivables | The increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables. |
| Operating Lease Right Of Use Asset | us-gaap/2024 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Other Assets Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Other Assets, Noncurrent | Amount of noncurrent assets classified as other. |
| Stock Issued During Period Shares Conversion Of Convertible Securities | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Conversion of Convertible Securities | Number of shares issued during the period as a result of the conversion of convertible securities. | |
| Depreciation Depletion And Amortization | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization | The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. |
| Increase Decrease In Other Operating Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Other Operating Assets | Amount of increase (decrease) in operating assets classified as other. |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Marketable Securities Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Marketable Securities, Current | Amount of investment in marketable security, classified as current. |
| Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Accounts And Other Receivables Net Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Accounts and Other Receivables, Net, Current | Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
| Proceeds From Sale Maturity And Collection Of Shortterm Investments | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Sale, Maturity and Collection of Short-Term Investments | The cash inflow from sales, maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term. |
| Profit Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | Amount of increase (decrease) in accrued expenses, and obligations classified as other. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Operating Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Prepaid Expense And Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
| Proceeds From Issuance Initial Public Offering | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Issuance Initial Public Offering | The cash inflow associated with the amount received from entity's first offering of stock to the public. |
| Temporary Equity Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Temporary Equity, Shares Outstanding | The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. | |
| Deferred Offering Cost | 0000950170-25-069831 | 1 | 0 | monetary | D | D | Deferred Offering Cost | Deferred offering cost. |
| Deferred Offering Costs Unpaid And Accrued | 0000950170-25-069831 | 1 | 0 | monetary | I | C | Deferred Offering costs Unpaid And Accrued | Deferred offering costs, unpaid and accrued. |
| Payments Of Success Fee Or Long Term Debt | 0000950170-25-069831 | 1 | 0 | monetary | D | C | Payments Of Success Fee Or Long-Term Debt | Payments of success fee or long-term debt. |
| General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Investment Income Net Amortization Of Discount And Premium | us-gaap/2024 | 0 | 0 | monetary | D | C | Investment Income, Net, Amortization of Discount and Premium | Amount of accretion (amortization) of purchase discount (premium) on nonoperating securities. |
| Notes And Loans Receivable Net Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Financing Receivable, after Allowance for Credit Loss, Noncurrent | Amount, after allowance for credit loss, of financing receivable, classified as noncurrent. |
| Research And Development Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Stock Issued During Period Shares New Issues | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, New Issues | Number of new stock issued during the period. | |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
| Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Commitments And Contingencies | us-gaap/2024 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Increase Decrease In Accounts Payable | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Payments To Acquire Notes Receivable | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Notes Receivable | The cash outflow to acquire an agreement for an unconditional promise by the maker to pay the entity (holder) a definite sum of money at a future date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics. |
| Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Investment Income Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Investment Income, Interest | Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. |
| Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
| Other Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Nonoperating Income (Expense) | Amount of income (expense) related to nonoperating activities, classified as other. |
| Revenue From Contract With Customer Including Assessed Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Revenue from Contract with Customer, Including Assessed Tax | Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. |
| Stock Issued During Period Value New Issues | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. |
| Conversion Of Deferred Offering Costs | 0000950170-25-069831 | 1 | 0 | monetary | D | D | Conversion Of Deferred Offering Costs | Conversion of deferred offering costs. |
| Operating Lease Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
| Payments To Acquire Short Term Investments | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Short-Term Investments | The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term. |
| Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0000950170-25-069831 | 2 | 13 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0000950170-25-069831 | 2 | 14 | BS | 0 | H | Marketable Securities Current | us-gaap/2024 | Marketable securities | 0 |
| 0000950170-25-069831 | 2 | 15 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2024 | Prepaid expenses and other current assets | 0 |
| 0000950170-25-069831 | 2 | 16 | BS | 0 | H | Accounts And Other Receivables Net Current | us-gaap/2024 | Accounts receivable - other | 0 |
| 0000950170-25-069831 | 2 | 17 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
| 0000950170-25-069831 | 2 | 18 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Property and equipment, net | 0 |
| 0000950170-25-069831 | 2 | 19 | BS | 0 | H | Notes And Loans Receivable Net Noncurrent | us-gaap/2024 | Note receivable, net | 0 |
| 0000950170-25-069831 | 2 | 20 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2024 | Operating lease right-of-use assets | 0 |
| 0000950170-25-069831 | 2 | 21 | BS | 0 | H | Other Assets Noncurrent | us-gaap/2024 | Other assets | 0 |
| 0000950170-25-069831 | 2 | 22 | BS | 0 | H | Assets | us-gaap/2024 | Total assets | 0 |
| 0000950170-25-069831 | 2 | 25 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable | 0 |
| 0000950170-25-069831 | 2 | 26 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2024 | Operating lease liabilities, current portion | 0 |
| 0000950170-25-069831 | 2 | 27 | BS | 0 | H | Accrued Liabilities And Other Liabilities | us-gaap/2024 | Accrued expenses and other current liabilities | 0 |
| 0000950170-25-069831 | 2 | 28 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
| 0000950170-25-069831 | 2 | 29 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2024 | Operating lease liabilities, net of current portion | 0 |
| 0000950170-25-069831 | 2 | 30 | BS | 0 | H | Liabilities | us-gaap/2024 | Total liabilities | 0 |
| 0000950170-25-069831 | 2 | 31 | BS | 0 | H | Commitments And Contingencies | us-gaap/2024 | Commitments and contingencies | 0 |
| 0000950170-25-069831 | 2 | 35 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock, $0.0001 par value per share; 700,000,000 and 700,000,000 shares authorized as of March 31, 2025 and December 31, 2024, respectively; 76,221,289 and 76,154,783 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively | 0 |
| 0000950170-25-069831 | 2 | 36 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional paid-in capital | 0 |
| 0000950170-25-069831 | 2 | 37 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0000950170-25-069831 | 2 | 38 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total stockholders' equity | 0 |
| 0000950170-25-069831 | 2 | 39 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total liabilities and stockholders' equity | 0 |
| 0000950170-25-069831 | 3 | 12 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value | 0 |
| 0000950170-25-069831 | 3 | 13 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized | 0 |
| 0000950170-25-069831 | 3 | 14 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares issued | 0 |
| 0000950170-25-069831 | 3 | 15 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common Stock, shares outstanding | 0 |
| 0000950170-25-069831 | 4 | 2 | IS | 0 | H | Revenue From Contract With Customer Including Assessed Tax | us-gaap/2024 | License and collaboration revenue | 0 |
| 0000950170-25-069831 | 4 | 4 | IS | 0 | H | Research And Development Expense | us-gaap/2024 | Research and development | 0 |
| 0000950170-25-069831 | 4 | 5 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | General and administrative | 0 |
| 0000950170-25-069831 | 4 | 6 | IS | 0 | H | Operating Expenses | us-gaap/2024 | Total operating expenses | 0 |
| 0000950170-25-069831 | 4 | 7 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Loss from operations | 0 |
| 0000950170-25-069831 | 4 | 9 | IS | 0 | H | Investment Income Interest | us-gaap/2024 | Interest income, net | 0 |
| 0000950170-25-069831 | 4 | 10 | IS | 0 | H | Other Nonoperating Income Expense | us-gaap/2024 | Other income (expense), net | 0 |
| 0000950170-25-069831 | 4 | 11 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2024 | Total other income, net | 0 |
| 0000950170-25-069831 | 4 | 12 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss and comprehensive loss | 0 |
| 0000950170-25-069831 | 4 | 14 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Net loss per share , basic | 0 |
| 0000950170-25-069831 | 4 | 15 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Net loss per share , diluted | 0 |
| 0000950170-25-069831 | 4 | 16 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Weighted average shares of common stock outstanding, basic | 0 |
| 0000950170-25-069831 | 4 | 17 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Weighted average shares of common stock outstanding, diluted | 0 |
| 0000950170-25-069831 | 5 | 20 | EQ | 0 | H | Temporary Equity Shares Outstanding | us-gaap/2024 | Beginning balance, shares | 0 |
| 0000950170-25-069831 | 5 | 21 | EQ | 0 | H | Temporary Equity Carrying Amount Attributable To Parent | us-gaap/2024 | Beginning balance | 0 |
| 0000950170-25-069831 | 5 | 22 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Beginning balance, shares | 0 |
| 0000950170-25-069831 | 5 | 23 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Beginning balance | 0 |
| 0000950170-25-069831 | 5 | 24 | EQ | 0 | H | Temporory Equity Issued During Period Shares Conversion Of Convertible Securities | 0000950170-25-069831 | Conversion of redeemable convertible preferred stock, shares | 0 |
| 0000950170-25-069831 | 5 | 25 | EQ | 0 | H | Temporory Equity Issued During Period Value Conversion Of Convertible Securities | 0000950170-25-069831 | Conversion of redeemable convertible preferred stock, value | 0 |
| 0000950170-25-069831 | 5 | 26 | EQ | 0 | H | Stock Issued During Period Shares Conversion Of Convertible Securities | us-gaap/2024 | Conversion of redeemable convertible preferred stock, shares | 0 |
| 0000950170-25-069831 | 5 | 27 | EQ | 0 | H | Stock Issued During Period Value Conversion Of Convertible Securities | us-gaap/2024 | Conversion of redeemable convertible preferred stock, value | 0 |
| 0000950170-25-069831 | 5 | 28 | EQ | 0 | H | Stock Issued During Period Shares New Issues | us-gaap/2024 | Issuance of common stock, net of issuance costs, shares | 0 |
| 0000950170-25-069831 | 5 | 29 | EQ | 0 | H | Stock Issued During Period Value New Issues | us-gaap/2024 | Issuance of common stock, net of issuance costs | 0 |
| 0000950170-25-069831 | 5 | 30 | EQ | 0 | H | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | Stock-based compensation expense | 0 |
| 0000950170-25-069831 | 5 | 31 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0000950170-25-069831 | 5 | 32 | EQ | 0 | H | Temporary Equity Shares Outstanding | us-gaap/2024 | Ending balance, shares | 0 |
| 0000950170-25-069831 | 5 | 33 | EQ | 0 | H | Temporary Equity Carrying Amount Attributable To Parent | us-gaap/2024 | Ending balance | 0 |
| 0000950170-25-069831 | 5 | 34 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Ending balance, shares | 0 |
| 0000950170-25-069831 | 5 | 35 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Ending balance | 0 |
| 0000950170-25-069831 | 6 | 2 | CF | 0 | H | Profit Loss | us-gaap/2024 | Net loss | 0 |
| 0000950170-25-069831 | 6 | 4 | CF | 0 | H | Depreciation Depletion And Amortization | us-gaap/2024 | Depreciation and amortization | 0 |
| 0000950170-25-069831 | 6 | 5 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Stock-based compensation expense | 0 |
| 0000950170-25-069831 | 6 | 6 | CF | 0 | H | Investment Income Net Amortization Of Discount And Premium | us-gaap/2024 | Accretion of discount on short-term investments | 1 |
| 0000950170-25-069831 | 6 | 7 | CF | 0 | H | Other Noncash Income | us-gaap/2024 | Non-cash interest income | 1 |
| 0000950170-25-069831 | 6 | 8 | CF | 0 | H | Non Cash Lease Expense | 0000950170-25-069831 | Non-cash lease expense | 0 |
| 0000950170-25-069831 | 6 | 10 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | Prepaid expenses and other current assets | 1 |
| 0000950170-25-069831 | 6 | 11 | CF | 0 | H | Increase Decrease In Accounts And Other Receivables | us-gaap/2024 | Accounts receivable - other | 1 |
| 0000950170-25-069831 | 6 | 12 | CF | 0 | H | Increase Decrease In Other Operating Assets | us-gaap/2024 | Other assets | 1 |
| 0000950170-25-069831 | 6 | 13 | CF | 0 | H | Increase Decrease In Accounts Payable | us-gaap/2024 | Accounts payable | 0 |
| 0000950170-25-069831 | 6 | 14 | CF | 0 | H | Increase Decrease In Accrued Liabilities And Other Operating Liabilities | us-gaap/2024 | Accrued expenses and other current liabilities | 0 |
| 0000950170-25-069831 | 6 | 15 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash used in operating activities | 0 |
| 0000950170-25-069831 | 6 | 17 | CF | 0 | H | Proceeds From Sale Maturity And Collection Of Shortterm Investments | us-gaap/2024 | Proceeds from sales and maturities of short-term investments | 0 |
| 0000950170-25-069831 | 6 | 18 | CF | 0 | H | Payments To Acquire Short Term Investments | us-gaap/2024 | Purchases of short-term investments | 1 |
| 0000950170-25-069831 | 6 | 19 | CF | 0 | H | Payments To Acquire Notes Receivable | us-gaap/2024 | Issuance of note receivable | 1 |
| 0000950170-25-069831 | 6 | 20 | CF | 0 | H | Payments To Acquire Property Plant And Equipment | us-gaap/2024 | Purchases of property and equipment | 1 |
| 0000950170-25-069831 | 6 | 21 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash used in investing activities | 0 |
| 0000950170-25-069831 | 6 | 23 | CF | 0 | H | Proceeds From Issuance Initial Public Offering | us-gaap/2024 | Proceeds from initial public offering, net of issuance costs | 0 |
| 0000950170-25-069831 | 6 | 24 | CF | 0 | H | Payments Of Success Fee Or Long Term Debt | 0000950170-25-069831 | Payments of success fee or long-term debt | 1 |
| 0000950170-25-069831 | 6 | 25 | CF | 0 | H | Proceeds From Stock Options Exercised | us-gaap/2024 | Proceeds from exercise of common stock options and issuance of common stock under the employee stock purchase plan | 0 |
| 0000950170-25-069831 | 6 | 26 | CF | 0 | H | Deferred Offering Cost | 0000950170-25-069831 | Deferred offering costs | 0 |
| 0000950170-25-069831 | 6 | 27 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash provided by financing activities | 0 |
| 0000950170-25-069831 | 6 | 28 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | Net (decrease) increase in cash and cash equivalents | 0 |
| 0000950170-25-069831 | 6 | 29 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents at beginning of period | 0 |
| 0000950170-25-069831 | 6 | 30 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents at end of period | 0 |
| 0000950170-25-069831 | 6 | 32 | CF | 0 | H | Reclassification Of Redeemable Convertible Preferred Stock To Common Stock | 0000950170-25-069831 | Reclassification of 38,413,909 redeemable convertible preferred stock to 38,413,909 shares of common stock | 0 |
| 0000950170-25-069831 | 6 | 33 | CF | 0 | H | Conversion Of Deferred Offering Costs | 0000950170-25-069831 | Conversion of deferred offering costs | 0 |
| 0000950170-25-069831 | 6 | 34 | CF | 0 | H | Deferred Offering Costs Unpaid And Accrued | 0000950170-25-069831 | Deferred offering costs, unpaid and accrued | 0 |
| 0000950170-25-069831 | 6 | 35 | CF | 0 | H | Right Of Use Asset Obtained In Exchange For Operating Lease Liability | us-gaap/2024 | Operating lease right-of-use asset obtained in exchange for new operating lease liabilities | 0 |
| 0000950170-25-069831 | 7 | 1 | CF | 1 | H | Temporory Equity Issued During Period Shares Conversion Of Convertible Securities | 0000950170-25-069831 | Reclassification of redeemable convertible preferred stock | 0 |
| 0000950170-25-069831 | 7 | 2 | CF | 1 | H | Stock Issued During Period Shares Conversion Of Convertible Securities | us-gaap/2024 | Reclassification of common stock | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |